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Abstract Drosophila alcohol dehydrogenase (DADH) belongs 
to the large and highly heterogeneous (15-30% residue identity) 
short-chain dehydrogenase/reductase family (SDR). It is the only 
reported member that oxidizes mainly ethanol and 2-propanol 
among other alcohols. To confirm the role of Ser1 3 9 we 
constructed two site-directed mutants, Ser139 Ala and Ser1 3 9Cys, 
which show no enzymatic activity. Molecular replacement and 
data from crystallographically refined 3D structures confirm the 
position of Ser1 3 9 , whose hydroxyl group faces the cleft of the 
presumed catalytic pocket, very close to Tyr1 5 2 and Lys 1 5 6 . 
Thus, consistent with the constitution of the catalytic triad of 
other SDR, our results suggest that Ser1 3 9 of DADH is directly 
involved in the catalytic reaction. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Drosophila alcohol dehydrogenase ( D A D H , alcohol, NAD+ 
oxidoreductase, E.C. 1.1.1.1) catalyzes the oxidation of alco-
hols, mainly ethanol and 2-propanol, to the corresponding 
aldehydes and ketones [1]. This enzyme, active as a Zn-free 
dimer composed of identical subunits of 253 to 255 amino 
acids, plays a key role in the detoxification and metabolic 
assimilation of alcohols generated by microbial fermentation 
in the feeding niches exploited by Drosophila. D A D H is a 
short-chain dehydrogenase/reductase (SDR) [2], an extended 
protein family, whose members show highly diverse functions, 
structure, subunit number and tissue distribution. Many pri-
mary structures for D A D H have been reported, 57 sequences 
belonging to 45 Drosophila species, and the refined 3D struc-
ture of D A D H is soon available [3]. 
Involvement of Tyr152 and Lys'°6 in the substrate-interac-
tive domain of D A D H was predicted in 1981 [4], later con-
firmed by biochemical data [5], chemical modification [6,7] 
and site-directed-mutagenesis [8-10]. In this paper we focus 
on position Ser139 whose fundamental importance in catalysis 
is also stressed in most SDR enzymes. Actually, from the four 
available SDR 3-D structures [11-16], these three amino acids 
have been referred to as the SDR 'catalytic triad' . To evaluate 
the role of Ser139 in catalysis in D A D H , two site-directed 
mutants , Ser139Ala and Ser139Cys, were expressed in E. coli, 
purified and analyzed for enzymatic activities. Meanwhile, 
based on our crystallographic data, a segment containing 
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the Ser1 3 9-Tyr1 5 2-Lys'°6 triad of D A D H has been superim-
posed on the 3oc,20|3-HSDH, D H P R and E. coli uridine di-
phosphogalactose 4-epimerase (UDP) and the C a least square 
distances were calculated. Overall, our data support the pre-
dicted involvement of Ser139 in catalysis and suggest similar-
ities in the reaction mechanism of D A D H with the reported 
SDR enzymes. 
2. Material and methods 
2.1. Site-directed mutagenesis and cloning of the Adh genes 
Drosophila melanogaster ADH mutants were constructed from the 
wild-type gene cloned in the expression vector pKK223-3 [9]. Mutant 
Ser139Cys was synthesized by a two-step PCR [17] using 5'-ACATTG-
GATGCGTCACTGGA-3' as mutagenic primer. Flanking primers 
were 5'-AAGAATTCACCATGTCGTTT-3', which introduced an 
£coRI site before the ATG codon and 5'-CCAAGCTTAGATGCCG-
GAGTCC-3', which introduced a Hindlll site after the stop codon. 
First PCR was performed in a final volume of 100 ul, containing 10 ng 
of template, 40 pmols of each primer, 200 uM of dNTPs and 2 u of 
Vent polymerase (New England Biolabs). Samples were kept at 94°C 
for 120 s and then 30 cycles were run in the following conditions: 60 s 
at 94°C, 60 s at 55°C, 60 s at 72°C. Products were purified after 
electrophoresis on 1.5% agarose gels. 30 cycles of the second PCR 
were performed at 55°C for the annealing step and in the previous 
conditions for the denaturation and elongation steps. The products of 
the second PCR were precipitated, digested with EcoRl and Hindlll 
and cloned in the pKK223-3 expression vector. Mutant Ser139Ala was 
generated according [18], using as mutagenic primer 5'-ACATTG-
GAGCCGTCACTGGA-3' and as flanking primers the same as those 
for the Ser139Cys gene construction. This mutagenesis method is per-
formed in three PCR steps by sequentially adding the primers. During 
all PCR steps conditions were 60 s at 94°C, 60 s at 55°C and 60 s at 
72°C. The first 10 cycles of the amplification were performed in a tube 
containing 10 ng of template, 20 pmols of the mutagenic and the 
downstream primers, 100 uM of dNTPs and 2 u of Vent polymerase. 
Then, 50 pmols of the upstream primer were added and the sample 
was amplified for a further 10 cycles. Finally, after adding 50 pmols of 
the downstream primer, the tube was subjected to the last 10 cycles. 
The PCR product was digested by EcoRl and Hindlll and cloned in 
pKK223-3. Transformed E. coli JM105 cells were first screened for the 
mutant gene forms by a BamHl digestion of their plasmid DNA, 
taking advantage of the loss of this restriction site when the TCC 
serine codon was replaced by either a TGC cysteine or a GCC alanine 
codon. The ADH coding region of positive clones was verified by 
sequencing of double-stranded DNA, using [a-3oS]dATP as radioac-
tive precursor and the Pharmacia Sequencing Kit. 
2.2. Expression and purification of ADH mutants 
10 ml of overnight cultures of the transformed E. coli cells in LB-
ampicillin were diluted to 100 ml with fresh medium and, after an 
additional 1 h (O.D. 0.6) and IPTG addition to 1 mM, cultures were 
incubated at 37°C for 3 h. Cells were harvested, washed twice in 
20 mM Tris-HCl pH 8.6 and resuspended in 5 ml of 20 mM Tris-
HC1 pH 8.6 supplemented with 5% 2-propanol and 1 mM DTT. 
Activity assays, SDS-PAGE, immunoblotting and ADH purification 
were carried out at 4°C using the crude supernatant obtained after cell 
disruption by sonication and centrifugation for 15 min. To purify the 
enzymes, bacterial protein extract was concentrated to 700 ul with 
Centriprep Concentrators (Amicon) with a cut-off of 10 kDa. 500 ul 
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of the concentrated solution was separated on FPLC MonoQ (Phar-
macia) in 20 mM Tris-HCl pH 8.6, supplemented with 5% 2-propanol 
and 1 mM DTT. The eluent contained mainly ADH, while most of 
the E. coli proteins remained bound to the gel matrix. ADH was 
further purified by FPLC Superdex 75 (Pharmacia) in the same buffer 
at 0.5 ml/min. Fractions were tested by SDS-electrophoresis and pro-
tein was quantified by the method of Bradford [19]. 
2.3. Recombinant ADH analysis 
SDS-PAGE was performed in 12.5% acrylamide gels with Coomas-
sie-blue staining. Western blotting was performed [20] using a mono-
clonal antibody against Drosophila ADH (LLBE8). ADH activity was 
measured spectrophotometrically by the increase in absorbance at 
340 nm, using 100 mM ethanol, 100 mM 1-propanol, 100 mM 2-
propanol, 100 mM 1-butanol and 50 mM 2-butanol and 1.8 mM 
NAD + . A range of pH's from 7.0 to 9.0 was assayed using 2-propanol 
as substrate. 
2.4. Structural analysis of the catalytic triad 
D. lebanonensis active site coordinates were from X-ray analysis data 
[3] and a refined crystallpgraphic model (i? = 20.1%, R[lee = 24.0%, 
resolution range = 8-1.92 A). Crystal structures were from the Brook-
haven Protein Data Bank (PDB): 3a,20B-HSDH (PDB code: 2HSD) 
[11,12], DHPR (PDB code: 1DHR) [15,21] and UDP (PDB code: 
1UDP) [22], Only Ca coordinates were available for UDP, so the 
program O [23] was used to build the main chain from Ca positions. 
Side-chains were chosen from the rotamer library facility of the same 
program and according to published data on the active site of UDP 
[22]. Comparison of the triad Ser-Tyr-Lys was performed by least 
squares superposition of 3a,20B-HSDH, DHPR and UDP Ca posi-
tions on DADH using the O program. The positions analyzed were: 
138-159 of DADH, 138-159 of 3a,20B-HSDH and 132-153 of 
DHPR. Due to an insertion, two segments of UDP (123-129 and 
147-156) were compared to DADH. Fig. 1 was produced in MOL-
SCRIPT [24] and rendered by RASTER3D [25,26], 
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3. Results 
3.1. Mutagenesis: purification and characterization 
of the mutant enzymes 
Landt's PCR procedure used to construct the Ser139Cys 
gene gave a unique product of the expected size (770 bp) 
but repeatedly failed to amplify a band of the correct size in 
the second step of the Ser139Ala mutagenic PCR. Thus, the 
Ser139Ala gene was constructed following Picard [18]. Se-
quencing of the mutant genes cloned in pKK223-3 revealed 
that the mutagenized codon was present and that no other 
unwanted substitutions had been introduced. SDS-PAGE of 
total protein extracts obtained from small scale cultures of the 
E. coli cells transformed with the plasmids containing the 
wild-type and the two mutants confirmed the synthesis of 
the three recombinant enzymes in similar yield. Recombinant 
D. melanogaster ADH did not bind to Blue Sepharose as 
other DADHs [27,28], but was purified in a 1 ml fraction of 
a Superdex 75 step in an alternative protocol [28]. The only 
band detectable by SDS-PAGE was recognized in Western 
blot analysis by the anti-Z). melanogaster-ADH mAb LLBE8. 
Concentrations of ADH in the purified preparations were 
0.235 ug/ul for the wild-type enzyme, 0.167 ug/ul for the 
Ser139Cys mutant and 0.135 ug/ul for the Ser139Ala mutant. 
Enzymatic assays performed under standard conditions (1 min 
at 25°C, using 2-propanol as substrate at pH 8.6) showed that 
while the wild-type form was fully active (0.801 mU/ul), nei-
ther mutant showed detectable activity. Activity was also 
checked with ethanol, 1-propanol, 1-butanol and 2-butanol 
at standard pH (8.6), and also at different pH's (7.0, 7.5, 
8.0 and 9.0) with 2-propanol. No detectable activity was re-
Fig. 1. Stereoview of the Ser139-Tyr152-Lys156 triad in the DADH active site based on a refined crystallographic structure, shown in ball-and-
stick representation. Secondary structure elements are represented as red ribbons for a-helices, green arrows for B-strands and yellow coils for 
loops and turns, generated in MOLSCRIPT [24] and rendered by RASTER3D [25,26]. 
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corded in any case, indicating that neither Ser139Cys nor 
Ser139Ala could oxidize any of the substrates. 
3.2. Relative position of Ser139 with respect to Tyr152 and 
Lys156 in DADH 
The conformation of the 138-158 protein segment was de-
picted based on a refined crystallographic model (Fig. 1). The 
spatial arrangement of Ser139 side-chain, facing Tyr152 and 
Lys156 fully confirms and extends the data obtained from 
site-directed mutagenesis. Least squares superposition of Coc 
atoms of D A D H with the corresponding regions of available 
crystal structures of 3cc,20P-HSDH, D H P R and U D P resulted 
in a root mean square deviation of: 1.1 A for 3a,20|3-HSDH, 
1.2 A for 6 ,7-DHPR and 1.0 A for U D P , showing that the 
active site geometries in those S D R members diverge quite a 
bit from D A D H . 
4. Discussion 
Suitable candidates for catalytic residues are those strictly 
conserved among the 57 reported D A D H . Of those, Tyr152 
and Lys156 had been previously confirmed by chemical mod-
ification and site-directed mutagenesis. Fur ther involve-
ment of Ser139 in D A D H , although supported by crystallo-
graphic da ta on four S D R enzymes, 3a,20|3-HSDH [11,12], 
17P-HSDH [13], M L C R [14] and D H P R [15], required experi-
mental confirmation. The null activity of the mutan t forms 
now reported validates the contribution of Ser139 to catalysis 
and highlights the need of a side-chain hydroxyl group, whose 
absence or replacement by a thiol leads to a dead enzyme. In 
agreement with our data a Ser138 Ala replacement of human 
15-hydroxyprostaglandin dehydrogenase, another S D R en-
zyme, produced crude extracts completely devoid of enzy-
matic activity [29], and substitution of Ser138 by Thr in 
3p,17P-HSDH yielded an active protein with identical cata-
lytic constants to the wild-type [16]. 
The structural information of the 138-158 fragment re-
ported in this work was obtained from the refined X ray 
structure of D A D H [3] and Benach et al. (to be published). 
Ser139 is located at the end of the strand PE, enclosed in the 
turn connecting PE and helix a F , Tyr152 is at the N-terminal 
end of the ocF-helix and Lys156 is in the same oc-helix (Fig. 1). 
The spatial configuration of the side chains of these three 
residues, all facing the inner side of the putative substrate 
binding pocket, supports their contribution to the reaction 
mechanism in full agreement with the catalytic triad of the 
'SDR ' family [2]. Our data on the Ser139 site-directed mutants , 
together with the previously reported chemical modification 
experiments [6,7] and amino acid substitutions on the Tyr152 
and Lys156 [8,9] highlight its direct contribution to catalysis. 
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